Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 109, Issue 2, 2010, Pages 257-267

  Hsieh, Pi Chuan ^a,b   Chen, Yuk Kwan ^c   Tsai, Kun Bow ^d   Shieh, Tien Yu ^c   Chang, Yong Yuan ^b   Chang, Jan Gowth ^a   Wu, Hsin Lung ^b   Lin, Sheng Fung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c Faculty of Dentistry   (Taiwan)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BUB1 SPINDLE CHECKPOINT PROTEIN; CELL CYCLE PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BIOSYNTHESIS; CASE CONTROL STUDY; CELL TRANSFORMATION; CHEMISTRY; ENZYME IMMUNOASSAY; ENZYMOLOGY; EPITHELIUM CELL; FEMALE; GENETICS; HUMAN; HYPERPLASIA; LICHEN PLANUS; MALE; MIDDLE AGED; MITOSIS SPINDLE; MOUTH DISEASE; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PRECANCER; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FEMALE; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; MITOTIC SPINDLE APPARATUS; MOUTH MUCOSA; MOUTH NEOPLASMS; ORAL SUBMUCOUS FIBROSIS; PRECANCEROUS CONDITIONS; PROTEIN-SERINE-THREONINE KINASES; TUMOR MARKERS, BIOLOGICAL; WARTS; YOUNG ADULT;

EID: 74149088596     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.08.014     Document Type: Article

References (44)

1. Misra S., Chaturvedi A., and Misra N.C. Oral carcinoma. In: Johnson C.D., and Taylor I. (Eds). Recent advances in surgery, volume 25 (2002), Royal Society of Medicine Press, London 71-86
2. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80 (1999) 827-841
3. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45 (2009) 317-323
4. Silverman Jr. S. Oral lichen planus: a potentially premalignant lesion. J Oral Maxillofac Surg 58 (2000) 1286-1288
5. Tilakaratne W.M., Klinikowski M.F., Saku T., Peters T.J., and Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42 (2006) 561-568
6. Kramer I.R., Lucas R.B., Pindborg J.J., and Sobin L.H. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46 (1978) 518-539
7. Shear M., and Pindborg J.J. Verrucous hyperplasia of the oral mucosa. Cancer 46 (1980) 1855-1862
8. Warnakulasuriya S., Reibel J., Bouquot J., and Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 37 (2008) 127-133
9. Cruz I., Napier S.S., van der Waal I., Snijders P.J., Walboomers J.M., Lamey P.J., et al. Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. J Clin Pathol 55 (2002) 98-104
10. Saunders W.S., Shuster M., Huang X., Gharaibeh B., Enyenihi A.H., Petersen I., et al. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci U S A 97 (2000) 303-308
11. Skoufias D.A., Andreassen P.R., Lacroix F.B., Wilson L., and Margolis R.L. Mammalian mad2 and bub1/bubR1 recognize distinct spindle-attachment and kinetochore-tension checkpoints. Proc Natl Acad Sci U S A 98 (2001) 4492-4497
12. Minhas K.M., Singh B., Jiang W.W., Sidransky D., and Califano J.A. Spindle assembly checkpoint defects and chromosomal instability in head and neck squamous cell carcinoma. Int J Cancer 107 (2003) 46-52
13. Mondal G., Sengupta S., Panda C.K., Gollin S.M., Saunders W.S., and Roychoudhury S. Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis 28 (2007) 81-92
14. Thirthagiri E., Robinson C.M., Huntley S., Davies M., Yap L.F., Prime S.S., et al. Spindle assembly checkpoint and centrosome abnormalities in oral cancer. Cancer Lett 258 (2007) 276-285
15. Poetsch M., and Kleist B. Loss of heterozygosity at 15q21.3 correlates with occurrence of metastases in head and neck cancer. Mod Pathol 19 (2006) 1462-1469
16. Taylor S.S., Ha E., and McKeon F. The human homologue of Bub3 is required for kinetochore localization of Bub1 and a Mad3/Bub1-related protein kinase. J Cell Biol 142 (1998) 1-11
17. Jablonski S.A., Chan G.K., Cooke C.A., Earnshaw W.C., and Yen T.J. The hBUB1 and hBUBR1 kinases sequentially assemble onto kinetochores during prophase with hBUBR1 concentrating at the kinetochore plates in mitosis. Chromosoma 107 (1998) 386-396
18. Seike M., Gemma A., Hosoya Y., Hosomi Y., Okano T., Kurimoto F., et al. The promoter region of the human BUBR1 gene and its expression analysis in lung cancer. Lung Cancer 38 (2002) 229-234
19. Li W., Lan Z., Wu H., Wu S., Meadows J., Chen J., et al. BUBR1 phosphorylation is regulated during mitotic checkpoint activation. Cell Growth Differ 10 (1999) 769-775
20. Baker D.J., Jeganathan K.B., Cameron J.D., Thompson M., Juneja S., Kopecka A., et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 36 (2004) 744-749
21. Matsumoto T., Baker D.J., d'Uscio L.V., Mozammel G., Katusic Z.S., and van Deursen J.M. Aging-associated vascular phenotype in mutant mice with low levels of BubR1. Stroke 38 (2007) 1050-1056
22. Rao C.V., Yang Y.M., Swamy M.V., Liu T., Fang Y., Mahmood R., et al. Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proc Natl Acad Sci U S A 102 (2005) 4365-4370
23. Shichiri M., Yoshinaga K., Hisatomi H., Sugihara K., and Hirata Y. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res 62 (2002) 13-17
24. Grabsch H., Takeno S., Parsons W.J., Pomjanski N., Boecking A., Gabbert H.E., et al. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer-association with tumor cell proliferation. J Pathol 200 (2003) 16-22
25. Yamamoto Y., Matsuyama H., Chochi Y., Okuda M., Kawauchi S., Inoue R., et al. Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer. Cancer Genet Cytogenet 174 (2007) 42-47
26. Scintu M., Vitale R., Prencipe M., Gallo A.P., Bonghi L., Valori V.M., et al. Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma. Cancer Lett 254 (2007) 298-307
27. Pinto M., Vieira J., Ribeiro F.R., Soares M.J., Henrique R., Oliveira J., et al. Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas. Cell Oncol 30 (2008) 389-395
28. Wada N., Yoshida A., Miyagi Y., Yamamoto T., Nakayama H., Suganuma N., et al. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature. Anticancer Res 28 (2008) 139-144
29. Pindborg J.J., Daftary D.K., and Mehta F.S. A follow-up study of sixty-one oral dysplastic precancerous lesions in Indian villagers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 43 (1977) 383-390
30. Lumerman H., Freedman P., and Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79 (1995) 321-329
31. Wright A., and Shear M. Epithelial dysplasia immediately adjacent to oral squamous cell carcinoma. J Oral Pathol 14 (1985) 559-564
32. Giorno R. A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. Diagn Immunol 2 (1984) 161-166
33. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
34. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instability in colorectal cancers. Nature 386 (1997) 623-627
35. Shin H.J., Baek K.H., Jeon A.H., Park M.T., Lee S.J., Kang C.M., et al. Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability. Cancer Cell 4 (2003) 483-497
36. Oikawa T., Okuda M., Ma Z., Goorha R., Tsujimoto H., Inokuma H., et al. Transcriptional control of BubR1 by p53 and suppression of centrosome amplification by BubR1. Mol Cell Biol 25 (2005) 4046-4061
37. Olesen S.H., Thykjaer T., and Ørntoft T.F. Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity. Carcinogenesis 22 (2001) 813-815
38. Davenport J.W., Fernandes E.R., Harris L.D., Neale G.A., and Goorha R. The mouse mitotic checkpoint gene bub1b, a novel bub1 family member, is expressed in a cell cycle-dependent manner. Genomics 55 (1999) 113-117
39. Baker D.J., Perez-Terzic C., Jin F., Pitel K., Niederländer N.J., Jeganathan K., et al. Opposing roles for p16 Ink4a and p19 Arf in senescence and ageing caused by BubR1 insufficiency. Nat Cell Biol 10 (2008) 825-836
40. Campo-Trapero J., Cano-Sanchez J., Palacios-Sanchez B., Llamas-Martinez S., Lo Muzio L., and Bascones-Martinez A. Cellular senescence in oral cancer and precancer and treatment implications: a review. Acta Oncol 47 (2008) 1464-1474
41. Cahill D.P., Lengauer C., Yu J., Riggins G.J., Willson J.K., Markowitz S.D., et al. Mutations of mitotic checkpoint genes in human cancers. Nature 392 (1998) 300-303
42. Yamaguchi K., Okami K., Hibi K., Wehage S.L., Jen J., and Sidransky D. Mutation analysis of hBUB1 in aneuploid HNSCC and lung cancer cell lines. Cancer Lett 139 (1999) 183-187
43. Hernando E., Orlow I., Liberal V., Nohales G., Benezra R., and Cordon-Cardo C. Molecular analysis of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer. Int J Cancer 95 (2001) 223-227
44. Braakhuis B.J., Tabor M.P., Kummer J.A., Leemans C.R., and Brakenhoff R.H. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63 (2003) 1727-1730